Postmarket Experience With HeartMate 3 Left Ventricular Assist Device: 30-Day Outcomes From the ELEVATE Registry-Reference-Cited by-同舟云学术

Postmarket Experience With HeartMate 3 Left Ventricular Assist Device: 30-Day Outcomes From the ELEVATE Registry

Published:2019-01 Issue:1 Volume:107 Page:33-39
ISSN:0003-4975
Container-title:The Annals of Thoracic Surgery
language:en
Short-container-title:The Annals of Thoracic Surgery

Author:

Garbade Jens,Gustafsson Finn,Shaw Steven,Lavee Jacob,Saeed Diyar,Pya Yuriy,Krabatsch Thomas,Schmitto Jan D.,Morshuis Michiel,Chuang Joyce,Zimpfer Daniel

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference21 articles.

1. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients;Rogers;J Am Coll Cardiol,2010

3. Prospective, multicenter study of ventricular assist device infections;Gordon;Circulation,2013

4. The incidence, predictors and outcomes of gastrointestinal bleeding in patients with left ventricular assist device (LVAD);Jabbar;Dig Dis Sci,2015

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fully magnetically centrifugal left ventricular assist device and long-term outcomes: the ELEVATE registry;European Heart Journal;2023-11-30

2. Role of Genetic Polymorphisms in the Development of Complications in Patients with Implanted Left Ventricular Assist Devices: HeartWare, HeartMate II, and HeartMate 3;Journal of Clinical Medicine;2023-11-22

3. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Circulation;2022-05-03

4. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure;Journal of the American College of Cardiology;2022-05

5. Leveraging real‐world evidence for determining performance goals for medical device studies;Statistics in Medicine;2021-09-24